As an NCI-designated Comprehensive Cancer Center, Moores Cancer Center at UC San Diego Health is among the top 4% of approximately 1,500 cancer centers in the United States, and one of only 58 Comprehensive Cancer Centers in the nation. Approximately 43,000 patients with cancer are seen at UC San Diego Health annually. Patients have access to clinical trials with a dedicated team, as well as to physicians who provide personalized care and are setting treatment standards nationwide for more than 200 types of cancer. According to the 2025-2026 U.S. News & World Report “Best Hospitals” survey, the UC San Diego Health cancer program was ranked 42nd in the nation.
Twist Bioscience
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. | At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and defense, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com.
Turbine
Turbine is virtualizing biological experiments with AI to accelerate drug discovery and improve clinical translatability. Using its foundational virtual cell model powered by its lab-in-the-loop, Turbine creates virtual copies of experimental assays. Running experiments at computational speed and scale allows researchers to test millions of ideas, beyond physical lab constraints, to understand biological drivers of disease. Working with scientists at leading biopharma like MSD (Merck & Co.), AstraZeneca and Bayer, Turbine’s virtual assays have rationalized experiments across more than 30 discovery programs. Backed by leading tech and industry investors like Accel, MSD Global Health Innovation Fund, Interactive Venture Partners and Beiersdorf, Turbine is turning biology into an engineering discipline.
TubeWriter
TubeWriter labeling systems is a full-feature instrument for printing directly at high-speed on the sides and caps of plastic, glass, and curved surfaces, including tubes, vials, slides, plates and custom labware. It is designed to address automating laboratory printing for assays, protocols and experiments. TubeWriter labeling withstands the harshest of lab conditions; resistant to chemical solvents and surviving long-term storage at -80C and liquid nitrogen. | TubeWriter is an automated labeling systems that prints directly on the surface of any labware eliminating the need for sticky labels. For laboratories that perform medium to high-throughput applications struggling with manual labeling or paper labels, the TubeWriter prints directly on the sides and caps of tubes, vials, plates and unique labware. TubeWriter prints text, images, and barcodes using UV-curable ink that withstands extreme lab conditions, most harsh chemicals and long-term storage at -80C and liquid nitrogen.
TOYOBO USA
In the 1950s, TOYOBO began investigating microorganisms for treating waste water from one of our plants that processed pulp for rayon. Scientists in our laboratories discovered that a certain type of yeast was consuming sugar in the waste water, substantially reducing the biochemical oxygen demand (BOD) level. We then filtered out the yeast to market it for animal food. As the proportion of nucleic acids in the yeast was extremely high, we separated them out and did research for use in food seasonings. In the 1960s, based on a success in commercializing uricase from Candida sp., the first of its kind, we expanded our focus to include the field of clinical chemistry. Now TOYOBO excels in the market with more than 60 kinds of material enzymes for diagnostic reagents. We also provide many kinds of materials and kits for research use at the forefront of the field of molecular biology. TOYOBO Healthcare products are renowned both in Japan and around the world for the finest level of quality on the market.
Tempus
AI-enabled precision medicine. Bringing the power of data and artificial intelligence to healthcare. | Tempus is a technology company leading the adoption of AI to advance precision medicine and patient care in psychiatry.
Tecan
At Tecan we are driven to improve people’s lives and health. We do this by empowering our customers to scale healthcare innovation globally from life science to the clinic. We collaborate with our customers in healthcare and the life sciences, from early-stage innovation through project implementation and beyond. We deliver the products, services and solutions that make lab processes and medical procedures precise, reproducible and compliant. This leads to scalable outcomes that are further reaching and ever more valuable to humankind. | Tecan is a global leader in life sciences and diagnostics, offering cutting-edge solutions that span genomics, automation, and personalized medical research. With a strong focus on workflow integration, Tecan delivers modular platforms and reagents that support every step of the genomics pipeline—from nucleic acid purification and quantification to PCR setup and next-generation sequencing (NGS) library preparation. Tecan’s automation systems, including MagicPrep® NGS and DreamPrep® NGS, provide walkaway solutions that simplify complex protocols, reduce errors, and increase throughput. These platforms enable broad and targeted genomic applications, which streamlines sequencing workflows for infectious disease and oncology research. Tecan’s commitment to standardization, scalability, and sustainability makes it a trusted partner for academic, clinical, and industrial research labs worldwide. By integrating automation with advanced reagents and collaborative development, Tecan is helping transform research into real-world medical impact. | Tecan supports the full product journey for complex MedTech, IVD, and life science systems, from critical components through development and manufacturing. Our teams specialize in high-mix, high-complexity programs that require disciplined processes and dependable execution. Through our contract manufacturing capabilities, we combine structured design transfer and vPoke® computer-directed assembly to deliver consistent results from pilot builds through scale. In parallel, our Cavro® components team provides precision liquid handling solutions that form the foundation of many complex instruments. With manufacturing in the US and Malaysia, FDA-approved facilities, and decades of experience across regulated industries, Tecan helps teams move forward with confidence, predictability, and long-term support. | Tecan is uniquely qualified to solve your most difficult technology and product-design problems. Our approach blends fundamental science and engineering to deliver limitless technology development. We take your ideas from concept to advanced functional prototype quickly, accurately and cost-effectively with our fixed price engagement model.
Takara Bio Inc.
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is committed to helping scientists break new ground with innovative technologies for the life sciences. Our extensive portfolio of reagents, instruments, and services supports advancements across many areas of research, development, frontline diagnostics, and clinical applications. Our parent company, Takara Bio Inc., is a leading provider of biotechnology equipment and reagents, and conducts research and development activities involving gene- and cell-based therapies. Together with its subsidiaries, Takara Bio Inc. is committed to preventing disease and improving the quality of life for all through the use of biotechnology.
Taconic Biosciences
Taconic Biosciences is a global leader in genetically engineered rodent models and services. Taconic provides the best animal solutions so that customers can acquire, generate, breed, precondition, test, and distribute valuable research models worldwide. Oncology offerings include exclusive GEMs, the NOG Portfolio, humanized immune system mice, and industry-leading model generation solutions.